Circulating-free DNA predicts response and treatment outcomes in BRAF mutation-positive melanoma

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • A study of patients with BRAF mutation-positive melanoma from 4 clinical trials consistently found improved progression-free survival and overall survival in those who tested negative for BRAF mutation-positive circulating-free DNA

Study Design

  • Study to assess association betw...